Letter: PNPLA3 and alcoholic liver disease – an alert to methodological limitations. Authors’ reply

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|41|6|594-594

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.6, 2015-03, pp. : 594-594

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letter: PNPLA3 and alcoholic liver disease ‐ an alert to methodological limitations

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 6, 2015-03 ,pp. : 593-593

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: association between moderate alcohol consumption and non‐alcoholic fatty liver disease – authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 11-12, 2015-12 ,pp. : 1331-1332

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: PNPLA3, metabolic syndrome and NAFLD status in obese subjects – authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 5, 2015-09 ,pp. : 630-631

John Wiley & Sons Inc

Access to resources Recommend Favorite

Commentary: dissecting the PNPLA3 association with liver fat and stiffness, and interaction with diet – authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 39, Iss. 8, 2014-04 ,pp. : 895-896

John Wiley & Sons Inc

Access to resources Recommend Favorite

PNPLA3 polymorphisms (rs738409) and non‐alcoholic fatty liver disease risk and related phenotypes: a meta‐analysis

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 5, 2015-05 ,pp. : 821-829

John Wiley & Sons Inc

Access to resources Recommend Favorite